Trials / Completed
CompletedNCT01656135
Reference Group Trial for The ONE Study
Reference Group Trial for The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- University of Regensburg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the progression of the immunological response in living-donor kidney transplant recipients treated with a standard immunosuppressive regimen. Clinical, immunological, and health-economic data collected during this Reference Group Trial will be used to corroborate historical renal transplantation statistics and generate reference ranges for future clinical studies that will test immunoregulatory cell therapy as an adjunct immunosuppressive treatment in renal transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood drawing for immune monitoring and questionnaires |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2012-08-02
- Last updated
- 2016-03-09
Locations
8 sites across 5 countries: United States, France, Germany, Italy, United Kingdom
Source: ClinicalTrials.gov record NCT01656135. Inclusion in this directory is not an endorsement.